Printer Friendly Font Sizedecreaseincrease


Obesity: An overview on its current perspectives and treatment options

Srinivas Nammi,1,3 Saisudha Koka,1 Krishna M Chinnala,2 and Krishna M Boini1,3



  • Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Over weight and obesity in the United States: Prevalence and trends, 19601994. Int J Obes Relat Metab Disord 1998;22:3947. [PubMed]

  • Bjorntorp P. Obesity. Lancet 1997;350:423426. [PubMed] [Full Text]

  • US Department of Health and Human Services. Office of the Surgeon General. The surgeon General’s call to action to prevent and decrease overweight and obesity. Rockville MD: United States Department of Health and Human Services. 2001.

  • Manson JE, Willett WC, Stamfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE. Body weight and mortality among women. N Eng J Med 1995;333:677685.

  • Blackburn GL. Effect of degree of weight loss on health benefits. Obes Res 1995;3:211s216s. [PubMed]

  • World Health Organization. Obesity: Preventing and managing the global epidemic. World Health Organisation Geneva. 2000.

  • Goldstein DJ. Beneficial health effects of a modest weight loss. Int J Obes Relat Metab Disord 1992;16:397415. [PubMed]

  • Bosello O, Armellini F, Zamboni M, Fitchet M. The benefits of modest weight loss in type-II diabetes. Int J Obes Relat Metab Disord 1997;21:S10S13. [PubMed]

  • Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D. Long term effects of modest weight loss in type-II diabetic patients. Arch Intern Med 1987;147:17491753. [PubMed]

  • Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 1998;67:4449. [PubMed] [Free Full Text]

  • Jacob CS, Katherine MH. Assessing obesity classification and epidemology. Br Med Bull 1997;2:239.

  • Zhang YY, Proencea R, Maffei M, Barone M, Leopold L, Friedman JM. Positional clone of the mouse obese gene and its human homologue. Nature 1994;372:425432. [PubMed] [Full Text]

  • Auwerx J, Stales B. Leptin. Lancet 1998;351:732742. [PubMed]

  • Andersson LB. Genes and obesity. Ann Med 1996;28:57. [PubMed]

  • Arner P. The 3-adrenergic receptor a cause & cure of obesity. N Engl J Med 1995;333:382383. [PubMed] [Full Text]

  • Chagnon YC, Perusse L, Weisnagel SJ, Rankinen T, Bouchard C. The human obesity gene map: the 1999 update. Obes Res 2000;8:89117. [PubMed] [Free Full Text]

  • Dryden S, Frankish H, Wang Q, Williams G. Neuropeptide Y and energy balance, one way ahead for the treatment of obesity? Eur J Clin Invest 1994;24:293308. [PubMed]

  • Flier JS, Flier EM. Obesity and the hypothalamus: Novel peptides for new pathways. Cell 1998;92:437440. [PubMed]

  • Friedman JM. The alphabet of weight control. Nature 1997;385:119120. [PubMed]

  • Shor Posnar G, Grinker JA, Marinescu C. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res Bull 1986;17:663671. [PubMed]

  • Dryden S, Frankish H, Wang Q, Williams G. The serotonin antagonist methysergide increase NPY synthesis and secretion in the hypothalamus of rat. Brain Res 1995;699:1218. [PubMed] [Full Text]

  • Boosalis MG, Gemayel N, Lee A, Bray GA, Laine L, Cohen H. Cholecystokinin and satiety: effect of hypothalamic obesity and gastric bubble insertion. Am J Physiol 1992;262:R241244. [PubMed] [Full Text]

  • Spiegelman BM, Flier JS. Adipogenesis and obesity: round in out the big picture. Cell 1996;87:377389. [PubMed]

  • Wadley J. Dietary restraint and binge eating behaviour. Anal Modif 1980;4:647660.

  • Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma rennin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981;304:930933. [PubMed]

  • Kolarzyk E, Kiec E, Wiater M. Effect of obesity on the ventilatory capacity of the respiratory system. I. Relation between basic spirometric indicators: vital capacity (VC) and forced expiratory volume (FEV1) and obesity. Med Pr 1985;36:8795. [PubMed]

  • Rahilly OS. Non insulin dependent diabetes mellitus: the gathering storm. Br Med J 1997;314:955960. [PubMed] [Free Full Text]

  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National health and Nutrition Examination survey. J Amer Med Assoc 2002;287:356359.

  • Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer_Davis E, Mooradian AD, Purnell JQ, Wheeler M. Evidence based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes care 2002;25:148198. [PubMed] [Free Full Text]

  • Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992;56:320328. [PubMed]

  • Anonymous. UK Prospective study on maturity onset diabetes. I. Effect of diet and sulphonylurea, insulin or biguainide therapy on fasting plasma glucose and body weight over one year. Diabetologia 1983;24:404411. [PubMed]

  • Davis MA, Neuhaus JM, Ettinger WH, Mueller WH. Body fat distributions and osteoarthritis. Am J Epidemiol 1990;132:701707. [PubMed]

  • Timothy PG. Key issues in the prevention of obesity. Br Med Bull 1997;53:359388. [PubMed]

  • US Institute of medicine. Reducing risks of mental disorders. Frontiers for preventive intervention research. Washington, National Academy Press; 1994.

  • Wadden TA. Treatment of obesity by moderate and severe caloric restriction results of clinical research tracts. Ann Intern Med 1993;119:688693. [PubMed]

  • Ashley JM, St Jeor ST, Schrage JP, Perumean_Chaney SE, Gilbertson MC, McCall NL, Bovee V. Weight control in the physician’s office. Arch Intern Med 2001;161:15991604. [PubMed] [Full Text]

  • Anderssen S, Holme I, Urdal P, Hjermann I. Diet and exercise intervention have favourable effects on blood pressure in hypertensives: The Oslo Diet and Exercise Study (ODES). Blood Press 1995;4:343349. [PubMed]

  • Bertram SR, Venter I, Stewart RI. Weight loss in obese women exercise vs dietary education. S Afr Med J 1990;78:1518. [PubMed]

  • Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT, Superko HR, Fortman SP, Albers JJ, Vranizan KM, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988;319:11731179. [PubMed]

  • Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G. Metabolic and weight loss effects of a long term dietary intervention in obese patients. Am J Clin Nutr 1999;69:198204. [PubMed] [Free Full Text]

  • US Department of Health and Human services. Leading health indicators. Overweight and obesity. Healthy people 2010 (Conference ed. in two volumes). DC US Department of Health and Human Services, Washington. 2000. p. 2445.

  • Wyatt, HR.; Wing, RR.; Hill, JO. The National weight control registry. In: Bessesen DH, Kushner RF, editor. Evaluation & Management of obesity. Philadelphia, Hanley & Belfus Inc; 2002. p. 199224.

  • Schoeller DA, Shay K, Kushner RF. How much physical activity is needed to minimize weight gain in previously obese women? Am J Clin Nutr 1997;66:551556. [PubMed]

  • Physical Activity and Health. A Report of the surgeon General PA. US Department of Health and Human services. 1996.

  • National Institutes of Health (NHLBI). Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. The evidence report Washington DC National Institute of Health, Obese Res 1998;6:51s201s.

  • Lessof MH, Myerson A. Benzedrine sulfate as an aid to be the treatment of obesity. N Engl J Med 1938;218:119205.

  • Connolly HM, Crary JL, McGoon MD, Hensud DD, Edwards BS, Edwards WD. Valvular heart disease associated with fenfluramine phentermine. N Engl J Med 1997;337:783. [PubMed] [Full Text]

  • James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000;356:21192125. [PubMed] [Full Text]

  • Mun EC, Blackbur GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology 2001;120:669681. [PubMed] [Full Text]

  • Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS. Sibutramine reduces food intake in non-dieting women with obesity. Obes Res 1998;6:111. [PubMed]

  • Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. Thermogenic effects of sibutramine in humans. Am J Clin Nutr 1998;68 :11801186. [PubMed] [Free Full Text]

  • Seagle HM, Bessesen DH, Hill JO. Effects of sibutramine on resting metabolic rate and weight loss in over weight women. Obes Res 1998;6:115121. [PubMed]

  • Astrup A, Toubro S. When, for whom and how to use sibutramine? Int J Obes Relat Metab Disord 2001;25:5257. Review.

  • Luque CA. Sibutramine: a serotonin-norepinephrine reuptake inhibitor for the treatment of obesity. Ann Pharmacother 1999;33:968978. [PubMed] [Full Text]

  • Sjostrom L, Rissonen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight in obese patients. European Multicenter Orlistat study group. Lancet 1998;352:167172. [PubMed] [Full Text]

  • Hill JO, Hauptman J, Anderson JW, Fujioka K, O'Neil PM, Smith DK, Zavoral JH, Aronne LJ. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-year study. Am J Clin Nutr 1999;69:11081116. [PubMed] [Free Full Text]

  • Mc Duffie JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. Effects of orlistat on fat soluble vitamins in obese adolescents. Pharmacotherapy 2002;22:814822. [PubMed]

  • Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J. Role of orlistat in the treatment of obese patients with type-2 diabetes. A 1-year randomized double blind study. Diabetes care 1998;21:12881294. [PubMed] [Free Full Text]

  • Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, Heimburger DC, Lucas CP, Robbins DC, Chung J, Heymsfield SB. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. J Amer Med Assoc 1999;281:235242.

  • Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med 2001;161:218227. [PubMed] [Full Text]

  • NHLBI. Prescription medication for treatment of obesity.

  • Rushing PA, Hagan MM, Seeley RJ, Lutz TA, Woods SC. Amylin: a novel action in the brain to reduce body weight. Endocrinology 2000;141:850853. [PubMed] [Free Full Text]

  • Stewart PM, Tomlinson JW. Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity. Trends Endocrinol Metab 2002;13:9496. [PubMed] [Full Text]

  • Clapham JC, Arch JRS, Tadayyon M. Anti-obesity drugs: a critical review of current therapies and future opportunities. Pharmacol Ther 2001;89:81121. [PubMed] [Full Text]

  • Anonymous. P 57 and food intake. obesity Meds and Research News. 2000.

  • Anonymous. NIH Conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991;115:956961. [PubMed]

  • Karl JG. Overview of surgical techniques for treating obesity. Am J Clin Nutr 1992;55:552s555s. [PubMed]

  • Ashley S, Bird DL, Sugden G, Royston CM. Vertical banded gastroplasty for the treatment of morbid obesity. Br J Surg 1993;80:14211423. [PubMed]

  • Shikora, SA.; Benotti, PN.; Forre, RA. Surgical Treatment of Obesity. In: Blackburn GL, Kanders BS, editor. Obesity, pathophysiology, psychology and treatment. New York Chapman & Hall; 1994. p. 264282.

  • Sagar PM. Surgical treatment of morbid obesity. Br J Surg 1995;82:732739. [PubMed]

  • Lonroth H, Dalenback J, Haglind E, Josefsson K, Olbe L, Fagevik Olsen M, Lundell L. Vertical banded gastroplasty by laparoscopic technique in the treatment of morbid obesity. Surg Laparosc Endosc 1996;6:102107. [PubMed]

  • Salmon PA, McArdle MO. The rationale and results of gastroplasty/gastric by-pass. Obes Surg 1992;2:6168. [PubMed] [Full Text]

  • Seehra H, Macc Dermatt N, Lascelles RG, Taylor TV. Wernicke’s encephalapathy after vertical banded gastroplasty for morbid obesity. Br Med J 1996;312:434. [PubMed] [Free Full Text]

  • Foley EF, Benotti PN, Borlase BC, Hollingshead J, Blackburn GL. Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg 1992;163:294297. [PubMed]

  • Carson JL, Ruddy ME, Duff AE, Holmes NJ, Cody RP, Brolin RE. The effect of gastric bypass surgery on hypertension in the morbidity obese patients. Arch Intern Med 1994;154:193200. [PubMed]

  • Olsson SA, Petersson BG, Sorbris R, Nilsson-Ehle P. Effects of weight reduction after gastroplasty on glucose and lipid metabolism. Am J Clin Nutr 1984;40:12731280. [PubMed]

  • Herbst CA, Hughes TA, Gwynne JT, Buckwalter JA. Gastric bariatric operation in insulin treated adults. Surgery 1984;95:209214. [PubMed]

  • Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339350. [PubMed]

Received February 28, 2004; Accepted April 14, 2004.


Srinivas Nammi,1,3 Saisudha Koka,1 Krishna M Chinnala,2 and Krishna M Boini1,3

1Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530003, Andhra Pradesh, INDIA

2University College of Pharmaceutical Sciences, Kakatiya University, Warangal 506009, Andhra Pradesh, INDIA

3Department of Physiology, University of Tuebingen, D 72076, Tuebingen, GERMANY

Corresponding author.


Nutr J. 2004; 3: 3.

doi: 10.1186/1475-2891-3-3. Published online 2004 April 14.